December 16, 2009
Galapagos
and GlaxoSmithKline broaden arthritis alliance
Download PDF
December 8, 2009
Galapagos
receives €4 M milestone for first clinical trial in
GlaxoSmithKline alliance
Download PDF
December 7, 2009
Galapagos
CEO increases shareholding
Download PDF
December 3, 2009
Galapagos
achieves multiple milestones in rheumatoid arthritis alliance
Download PDF
November 26, 2009
Galapagos
receives EUREKA innovation label and OSEO funding
Download PDF
November 17, 2009
Galapagos
initiates Nanocort® Phase II clinical trial for multiple
sclerosis
Download PDF
November 13, 2009
Galapagos
business update
Download PDF
October 16, 2009
Galapagos
successfully completes placement of 2,125,925 new ordinary
shares
Download PDF
October 15, 2009
Galapagos
announces offering of new ordinary shares
Download PDF
October 14, 2009
Galapagos
expands strategic alliance in metabolic disease with Merck
& Co., Inc.
Download PDF
October 7, 2009
Galapagos
achieves first milestone in anti-infectives alliance with
GlaxoSmithKline
Download PDF
September 24, 2009
Galapagos
announces expanded drug discovery collaboration with Schering-Plough
Download PDF
September 17, 2009
Galapagos
collaborates with Charley’s Fund, Nash Avery Foundation
to develop SARM candidate drug for Duchenne muscular dystrophy
Download PDF
September 10, 2009
Galapagos initiates second Phase I clinical trial for GLPG0259
Download PDF
August 7, 2009
Galapagos reports revenue growth and improved net result
in 1H 2009
Download PDF
August 6, 2009
Galapagos
successfully completes first Phase I study for GLPG0259
Download PDF
July 23, 2009
Galapagos
achieves milestone in osteoporosis collaboration with Lilly
Download PDF
July 7, 2009
Galapagos
delivers second pre-clinical candidate in alliance with
GlaxoSmithKline and receives €5.2 million in milestone
payments
Download PDF
June 30, 2009
Galapagos
awarded Innovative Enterprise qualification in France
Download PDF
Juin 30, 2009
Qualification
d’Entreprise innovante au titre des FCPI attribuée
à Galapagos
Download
PDF
June 16, 2009
Galapagos
initiates clinical studies with GLPG0187, a candidate drug
for bone metastasis
Download PDF
June 3, 2009
Galapagos
announces appointment of new CFO and Board Member;
creates new warrant plan
Download PDF
May 28, 2009
Galapagos
achieves milestone payment in rheumatoid arthritis alliance
Download PDF
May 15, 2009
Galapagos
business update
Download PDF
April 21, 2009
Galapagos
and Opsona Therapeutics initiate drug discovery collaboration
Download PDF
April 20, 2009
Galapagos
enters strategic alliance in inflammatory diseases with
Merck & Co., Inc.
Download PDF
April 1, 2009
Galapagos
creates new warrant plan
Download PDF
March 27, 2009
Galapagos
enters the clinic with rheumatoid arthritis candidate drug
View
webcast presentation
Download PDF
March 23, 2009
Galapagos
to present R&D update on 27 March 2009
Download PDF
March 6, 2009
Galapagos
confirms 2008 financial results, foresees strong growth
in 2009
View
webcast presentation
Download PDF
February 13, 2009
Galapagos
reveals key drug target for Alzheimer disease
Download PDF
February 11, 2009
Galapagos
awarded grant to accelerate drug discovery
Download PDF
January 28, 2009
Galapagos
2008 trading update and 2009 guidance
Download PDF
January 19, 2009
Galapagos
and GlaxoSmithKline expand anti-infectives alliance
Download PDF
January 14, 2009
Galapagos
achieves milestone payments for rheumatoid arthritis alliance
Download PDF
January 9, 2009
Galapagos
enters strategic alliance in diabetes and obesity with Merck
& Co., Inc.
View
webcast presentation
Download PDF
January 5, 2009
Galapagos
delivers pre-clinical candidate drug in alliance with GlaxoSmithKline
and receives €7.6 million in milestone payments
Download PDF
January 5, 2009
Galapagos
selects pre-clinical candidate drug for cachexia
Download PDF
Janvier 5, 2009
Galapagos
sélectionne un médicament candidat préclinique
pour traiter la cachexie
Download
PDF
